103.31
price up icon0.07%   0.07
after-market アフターアワーズ: 103.31
loading
前日終値:
$103.24
開ける:
$103.2
24時間の取引高:
1.74M
Relative Volume:
0.35
時価総額:
$19.62B
収益:
$3.08B
当期純損益:
$-986.58M
株価収益率:
-19.43
EPS:
-5.3172
ネットキャッシュフロー:
$292.08M
1週間 パフォーマンス:
-0.04%
1か月 パフォーマンス:
+0.86%
6か月 パフォーマンス:
+126.56%
1年 パフォーマンス:
+109.51%
1日の値動き範囲:
Value
$103.14
$103.41
1週間の範囲:
Value
$103.14
$103.50
52週間の値動き範囲:
Value
$38.81
$103.54

Exact Sciences Corp Stock (EXAS) Company Profile

Name
名前
Exact Sciences Corp
Name
セクター
Healthcare (1109)
Name
電話
608-284-5700
Name
住所
5505 ENDEAVOR LANE, MADISON, WI
Name
職員
7,000
Name
Twitter
@exactsciences
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
EXAS's Discussions on Twitter

Compare EXAS vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
103.31 19.61B 3.08B -986.58M 292.08M -5.3172
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
501.62 189.66B 44.56B 6.73B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
206.39 150.27B 24.57B 3.60B 5.25B 5.0475
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
626.17 50.25B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
123.90 35.58B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
WAT
Waters Corp
321.47 31.72B 3.17B 642.63M 539.81M 10.77

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-20 ダウングレード Mizuho Outperform → Neutral
2026-01-05 ダウングレード Evercore ISI Outperform → In-line
2025-04-10 開始されました Mizuho Outperform
2025-03-13 開始されました RBC Capital Mkts Sector Perform
2025-01-23 開始されました Barclays Overweight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Buy
2024-01-02 アップグレード The Benchmark Company Hold → Buy
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-10-10 アップグレード Piper Sandler Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-08-02 ダウングレード The Benchmark Company Buy → Hold
2023-05-10 アップグレード Craig Hallum Hold → Buy
2023-05-05 開始されました UBS Neutral
2023-03-09 アップグレード Citigroup Neutral → Buy
2023-02-10 ダウングレード Credit Suisse Outperform → Neutral
2023-01-18 ダウングレード Raymond James Outperform → Mkt Perform
2022-10-19 ダウングレード Craig Hallum Buy → Hold
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Neutral
2021-11-03 ダウングレード Raymond James Strong Buy → Outperform
2021-07-29 繰り返されました BTIG Research Buy
2021-07-29 繰り返されました Canaccord Genuity Buy
2021-07-29 繰り返されました Oppenheimer Outperform
2021-07-29 繰り返されました Stifel Buy
2021-06-15 開始されました Raymond James Strong Buy
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Equal Weight
2021-01-28 開始されました Truist Buy
2020-10-29 ダウングレード UBS Buy → Neutral
2020-10-28 ダウングレード Citigroup Buy → Neutral
2020-10-08 再開されました BTIG Research Buy
2020-04-02 開始されました Evercore ISI Outperform
2020-01-10 再開されました BTIG Research Buy
2020-01-07 開始されました Citigroup Buy
2019-12-13 開始されました Dougherty & Company Buy
2019-11-15 開始されました Stifel Buy
2019-10-17 繰り返されました BofA/Merrill Buy
2019-10-01 再開されました Craig Hallum Buy
2019-09-26 開始されました Oppenheimer Outperform
2019-02-26 アップグレード Goldman Neutral → Buy
2018-10-09 開始されました UBS Buy
2018-09-05 再開されました The Benchmark Company Hold
2018-08-13 繰り返されました Canaccord Genuity Buy
2018-04-03 アップグレード BTIG Research Neutral → Buy
2018-01-29 開始されました Goldman Neutral
2018-01-08 繰り返されました The Benchmark Company Buy
2017-11-13 ダウングレード Robert W. Baird Outperform → Neutral
2017-11-01 ダウングレード BTIG Research Buy → Neutral
すべてを表示

Exact Sciences Corp (EXAS) 最新ニュース

pulisher
01:31 AM

Exact Sciences (EXAS) Climbs to 2-Year High on Abbot Merger Reports - MSN

01:31 AM
pulisher
Feb 15, 2026

Exact Sciences Faces Rising Operational Risk and Strategic Constraints Amid Pending Abbott Merger - TipRanks

Feb 15, 2026
pulisher
Feb 14, 2026

Key facts: Exact Sciences to merge with Abbott by Q2 2026; 2025 revenue up 18% - TradingView

Feb 14, 2026
pulisher
Feb 14, 2026

Exact Sciences misses Q4 expectations for earnings, beats for revenue - Wisconsin State Journal

Feb 14, 2026
pulisher
Feb 14, 2026

Illinois Municipal Retirement Fund Boosts Stake in Exact Sciences Corporation $EXAS - MarketBeat

Feb 14, 2026
pulisher
Feb 14, 2026

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus

Feb 14, 2026
pulisher
Feb 13, 2026

Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences: Fourth Quarter Earnings Overview - Bitget

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences: Q4 Earnings Snapshot - kens5.com

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences (EXAS) Surpasses Q4 Revenue Expectations - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com

Feb 13, 2026
pulisher
Feb 13, 2026

EXACT SCIENCES CORP SEC 10-K Report - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences Corp. Reports Record Fourth Quarter and Full Year 2025 Results - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results - Business Wire

Feb 13, 2026
pulisher
Feb 13, 2026

Is It Too Late To Consider Exact Sciences (EXAS) After The US$105 Abbott Offer - Yahoo Finance

Feb 13, 2026
pulisher
Feb 12, 2026

Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - GlobeNewswire Inc.

Feb 12, 2026
pulisher
Feb 12, 2026

Alger Mid Cap 40 ETF Q4 2025 Portfolio Update - Seeking Alpha

Feb 12, 2026
pulisher
Feb 12, 2026

Exact Sciences Corporation (NASDAQ:EXAS) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

Take Profit: Will Exact Sciences Corporation benefit from green energy policiesLayoff News & Technical Buy Zone Confirmation - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 11, 2026

Aug PreEarnings: Will Exact Sciences Corporation outperform its industry peersQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Allianz Asset Management GmbH Makes New Investment in Exact Sciences Corporation $EXAS - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test - Mugglehead Magazine

Feb 11, 2026
pulisher
Feb 10, 2026

Exact Sciences (NASDAQ:EXAS) Sets New 12-Month HighTime to Buy? - MarketBeat

Feb 10, 2026
pulisher
Feb 09, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (NasdaqNFBK), Coterra Energy Inc. (NYSECTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – - ChartMill

Feb 09, 2026
pulisher
Feb 08, 2026

Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance

Feb 08, 2026
pulisher
Feb 08, 2026

Abbott to Buy Cancer-Screener Exact Sciences for $21 Billion - MSN

Feb 08, 2026
pulisher
Feb 06, 2026

Exact Sciences Milestone In Breast Cancer Genomics And What It Means For EXAS - Yahoo Finance

Feb 06, 2026
pulisher
Feb 06, 2026

PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test - Law360

Feb 06, 2026
pulisher
Feb 06, 2026

Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent - The AI Journal

Feb 06, 2026
pulisher
Feb 06, 2026

Exact Sciences (EXAS) Advances as HSR Period Expires for Abbott Deal - GuruFocus

Feb 06, 2026
pulisher
Feb 05, 2026

The Truth About Exact Sciences Corp: Is This Cancer-Test Stock Quietly Going Viral or About to Flop? - AD HOC NEWS

Feb 05, 2026
pulisher
Feb 05, 2026

Principal Financial Group Inc. Grows Position in Exact Sciences Corporation $EXAS - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

C WorldWide Group Holding A S Has $46.97 Million Holdings in Exact Sciences Corporation $EXAS - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

Exact Sciences Corporation $EXAS Shares Sold by Heritage Investors Management Corp - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

Medicare coverage pathway established for multi-cancer detection tests By Investing.com - Investing.com Nigeria

Feb 03, 2026
pulisher
Feb 03, 2026

Exact Sciences (EXAS) Applauds Medicare Coverage Pathway for Can - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

Medicare coverage pathway established for multi-cancer detection tests - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Exact Sciences welcomes Medicare coverage pathway for multi-cancer tests - StreetInsider

Feb 03, 2026
pulisher
Feb 03, 2026

Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests - Business Wire

Feb 03, 2026
pulisher
Feb 03, 2026

Exact Sciences (NASDAQ:EXAS) Hits New 12-Month HighShould You Buy? - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Pa - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

Exact Sciences stock hits 52-week high at $102.69 - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide - Business Wire

Feb 03, 2026
pulisher
Feb 03, 2026

Multiple Tailwinds Lifted Exact Sciences Corporation (EXAS) in 2025 - Insider Monkey

Feb 03, 2026
pulisher
Feb 03, 2026

Breast cancer test spares 1.6M from chemo, averages $10K lifetime savings - Stock Titan

Feb 03, 2026
pulisher
Feb 02, 2026

Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date - TechStock²

Feb 02, 2026
pulisher
Feb 02, 2026

Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset - Yahoo Finance

Feb 02, 2026
pulisher
Feb 01, 2026

Bear Alert: Is Exact Sciences Corporation showing insider buyingWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal - Yahoo Finance UK

Jan 31, 2026
pulisher
Jan 29, 2026

Freedom Capital Markets upgrades Abbott Labs stock rating to Buy on Exact Sciences deal - Investing.com

Jan 29, 2026
pulisher
Jan 28, 2026

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More - AOL.com

Jan 28, 2026

Exact Sciences Corp (EXAS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Exact Sciences Corp (EXAS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Baranick Brian
EVP, GM, Precision Oncology
Dec 23 '25
Option Exercise
0.00
73,080
0
66,487
Condella Sarah
EVP, Human Resources
Dec 23 '25
Option Exercise
0.00
47,208
0
118,059
Herriott James
SVP, General Counsel & Sec
Dec 23 '25
Option Exercise
0.00
33,780
0
32,934
Bloomer Aaron
EVP, Chief Financial Officer
Dec 23 '25
Option Exercise
0.00
63,099
0
59,571
ORVILLE JACOB A
EVP, GM, Screening
Nov 19 '25
Sale
75.00
5,000
375,000
23,237
Herriott James
SVP, General Counsel & Sec
Nov 19 '25
Sale
70.00
1,000
70,000
11,585
diagnostics_research LH
$268.87
price down icon 4.81%
diagnostics_research DGX
$207.14
price up icon 0.58%
diagnostics_research MTD
$1,365.29
price up icon 0.10%
diagnostics_research IQV
$165.82
price down icon 1.40%
$207.63
price down icon 0.47%
diagnostics_research WAT
$313.53
price down icon 2.60%
大文字化:     |  ボリューム (24 時間):